摘要
目的:分析巴戟天寡糖胶囊联合米那普仑治疗抑郁症的疗效。方法:2018年6月-2020年6月收治抑郁症患者60例,根据用药方案不同分为两组,各30例。观察组采取巴戟天寡糖胶囊联合米那普仑治疗,对照组采取米那普仑治疗,比较两组治疗效果。结果:观察组治疗总有效率明显高于对照组,差异有统计学意义(P<0.05);观察组治疗1个月、2个月及3个月的汉密尔顿抑郁量表评分均明显低于对照组,差异有统计学意义(P<0.05)。结论:巴戟天寡糖胶囊联合米那普仑治疗抑郁症,具有较好的临床疗效与安全性,能够有效改善患者的抑郁情绪。
Objective:To analyze the efficacy of Morinda officinalis oligosaccharide capsule combined with Milnacipran in the treatment of depression.Methods:From June 2018 to June 2020,60 patients with depression were selected and divided into two groups according to different medication regimens,with 30 cases in each group.Observation group was treated with Morinda officinalis oligosaccharide capsule combined with Milnacipran.The control group was treated with Milnacipran.The therapeutic effect between the two groups was compared.Results:The total effective rate of the observation group was significantly higher than the control group,with the differences were statistically significant(P<0.05).The HAMD scores of the observation group were significantly lower than the control group at 1,2 and 3 months after treatment,with the differences were statistically significant(P<0.05).Conclusion:Morinda officinalis oligosaccharide capsule combined with Milnacipran has good clinical efficacy and safety in the treatment of depression,and can effectively improve the depression mood of patients.
作者
谭文钟
尤晨
方建忠
赵胜军
Tan Wenzhong;You Chen;Fang Jianzhong;Zhao Shengjun(Third People's Hospital of Changshu City,Jiangsu Changshu 215500)
出处
《中国社区医师》
2021年第24期93-94,共2页
Chinese Community Doctors
关键词
巴戟天寡糖胶囊
米那普仑
抑郁症
Morinda officinalis oligosaccharide capsule
Milnacipran
Depression
